Buks, R.; Brusson, M.; Cochet, S.; Galochkina, T.; Cassinat, B.; Nemazanyy, I.; Peyrard, T.; Kiladjian, J.-J.; de Brevern, A.G.; Azouzi, S.;
et al. ABCG2 Is Overexpressed on Red Blood Cells in Ph-Negative Myeloproliferative Neoplasms and Potentiates Ruxolitinib-Induced Apoptosis. Int. J. Mol. Sci. 2021, 22, 3530.
https://doi.org/10.3390/ijms22073530
AMA Style
Buks R, Brusson M, Cochet S, Galochkina T, Cassinat B, Nemazanyy I, Peyrard T, Kiladjian J-J, de Brevern AG, Azouzi S,
et al. ABCG2 Is Overexpressed on Red Blood Cells in Ph-Negative Myeloproliferative Neoplasms and Potentiates Ruxolitinib-Induced Apoptosis. International Journal of Molecular Sciences. 2021; 22(7):3530.
https://doi.org/10.3390/ijms22073530
Chicago/Turabian Style
Buks, Ralfs, Mégane Brusson, Sylvie Cochet, Tatiana Galochkina, Bruno Cassinat, Ivan Nemazanyy, Thierry Peyrard, Jean-Jacques Kiladjian, Alexandre G. de Brevern, Slim Azouzi,
and et al. 2021. "ABCG2 Is Overexpressed on Red Blood Cells in Ph-Negative Myeloproliferative Neoplasms and Potentiates Ruxolitinib-Induced Apoptosis" International Journal of Molecular Sciences 22, no. 7: 3530.
https://doi.org/10.3390/ijms22073530
APA Style
Buks, R., Brusson, M., Cochet, S., Galochkina, T., Cassinat, B., Nemazanyy, I., Peyrard, T., Kiladjian, J.-J., de Brevern, A. G., Azouzi, S., & El Nemer, W.
(2021). ABCG2 Is Overexpressed on Red Blood Cells in Ph-Negative Myeloproliferative Neoplasms and Potentiates Ruxolitinib-Induced Apoptosis. International Journal of Molecular Sciences, 22(7), 3530.
https://doi.org/10.3390/ijms22073530
